Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post

CEPI allocated $60M to Moderna and partners for rapid Ebola Bundibugyo vaccine development with trials within months. The pace tests pandemic-era platform scalability while revealing manufacturing and trial logistics as the critical constraint for emergency response deployment.